Malek Mohammadi Yeganeh, Khaki Pejvak, Gharakhani Mehdi
Department of Microbiology, Agricultural Research, Education and Extension Organization (AREEO), Razi Vaccine and Serum Research Institute, Karaj, Iran.
J Trop Med. 2024 Dec 28;2024:3900663. doi: 10.1155/jotm/3900663. eCollection 2024.
The protein is highly conserved among pathogenic serovars and it is expressed during both acute and chronic infections. The aim of this study was to clone and sequence of the protein-encoding gene of serovars. In this study, 23 pathogenic serovars and two nonpathogenic serovars were used. These serovars were obtained from the microbial culture collection of Reference Laboratory, Department of Microbiology, Razi Vaccine and Serum Research Institute, Karaj, Iran. Three serovars, including Sejroe Hardjo-bovis, Grippotyphosa, Canicola, are used in the preparation of the trivalent vaccine. The gene was amplified by specific primers and the PCR products were then purified using kit and were cloned into a pTZ57R/T vector and transformed in competent DH5 cells. The cells were then plated onto LB agar containing ampicillin and recombinant colonies subjected to colony PCR to confirm the presence of the l gene. Positive colonies plasmid vector was isolated from cells by High Pure Plasmid Isolation Kit. The gene was detected in all 23 pathogenic serovars, while this gene was not observed in nonpathogenic It was determined that the similarity percentage of the sequenced pathogenic serovars is between 95.5% and 100%. The results concluded that the gene was highly conserved among various pathogenic serovars and can be used to develop an effective recombinant vaccine.
该蛋白质在致病性血清型中高度保守,在急性和慢性感染期间均有表达。本研究的目的是克隆和测序血清型的蛋白质编码基因。在本研究中,使用了23种致病性血清型和两种非致病性血清型。这些血清型取自伊朗卡拉季拉齐疫苗和血清研究所微生物学系参考实验室的微生物培养物保藏库。三种血清型,包括Sejroe Hardjo-bovis、Grippotyphosa、Canicola,用于制备三价疫苗。通过特异性引物扩增该基因,然后使用试剂盒纯化PCR产物,并将其克隆到pTZ57R/T载体中,转化到感受态DH5细胞中。然后将细胞接种到含有氨苄青霉素的LB琼脂平板上,对重组菌落进行菌落PCR以确认l基因的存在。通过高纯质粒分离试剂盒从细胞中分离出阳性菌落质粒载体。在所有23种致病性血清型中均检测到该基因,而在非致病性血清型中未观察到该基因。测定测序的致病性血清型的相似百分比在95.5%至100%之间。结果表明,该基因在各种致病性血清型中高度保守,可用于开发有效的重组疫苗。